XML 98 R82.htm IDEA: XBRL DOCUMENT
v3.21.2

Income Taxes - Valuation allowance (Details) - USD ($) $ in Thousands | 12 Months Ended |
--- | --- | ---
Jun. 30, 2021 | Jun. 30, 2020
Deferred Tax Assets, Net of Valuation Allowance [Abstract] |  |
Valuation allowance | $ 116,494 | $ 39,552
Neos Therapeutics, Inc. |  |
Deferred Tax Assets, Net of Valuation Allowance [Abstract] |  |
Valuation allowance, increase (decrease), amount | $ 62,500 |

X
- References No definition available. + Details
Name: | us-gaap_DeferredTaxAssetsNetOfValuationAllowanceAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319 + Details
Name: | us-gaap_DeferredTaxAssetsValuationAllowance
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319 + Details
Name: | us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=aytu_NeosTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |